Dot Medical Ltd, a Macclesfield, UK-based company that has manufactured a piece of equipment to treat a heart condition, has raised £550k in funding from The North West Fund for Biomedical, managed by SPARK Impact.
The company intends to use the capital to expand the number of centres treating Atrial Fibrillation (AF), a heart condition that causes an irregular and often abnormally-fast heart rate.
The funding will be used to develop and manufacture equipment for delivering energy to the ‘Alert’ catheter and enable the procedure to be more widely available in the UK and abroad mainly in China, India and the USA.
Dot Medical is les by Ian Rankin, managing director.
FinSMEs
31/07/2012